Laurence Albiges(@AlbigesL) 's Twitter Profile Photo

Pleased to share The Lancet Oncology LENVA-PEMBRO across RCC variant histologies: papillary RCC, unclRCC and chromophobe RCC … interim ESMO - Eur. Oncology and final Chung-Han Lee 李宗翰, MD/PhD ASCO

full text: authors.elsevier.com/a/1hP1c5EIIgLp…
Thanks to all who change
rareRCC pts Tx!

Pleased to share @TheLancetOncol LENVA-PEMBRO  across RCC variant histologies: papillary RCC, unclRCC and chromophobe RCC … interim @myESMO #ESMO22 and  final @ChungHanLee3  @ASCO #ASCO23 

full text: authors.elsevier.com/a/1hP1c5EIIgLp… 
Thanks to all who change 
 rareRCC pts Tx!
account_circle
Kekoa Taparra, MD, PhD(@KekoaMDPhD) 's Twitter Profile Photo

Embarrassed to say, but after 3 years of being safe, I finally got COVID for the first time. I honestly thought we were past this (society seems to have moved on) but clearly I was wrong.

Posting to bring awareness that we still need to at conferences ASTRO

Embarrassed to say, but after 3 years of being safe, I finally got COVID for the first time. I honestly thought we were past this (society seems to have moved on) but clearly I was wrong. 

Posting to bring awareness that we still need to #MaskUp at conferences #ASCO23 @ASTRO_org
account_circle
Talal El Zarif, MD(@TalalZarif1) 's Twitter Profile Photo

Excited to share our work The Oncologist on TERT promoter mutations by race, ethnicity, & cancer types - presented at & led w/ rising stars Rashad Nawfal, MD Marc Machaalani thanks to support of Toni Choueiri, MD Amin Nassar, MD Wanling

academic.oup.com/oncolo/advance…

account_circle
Dr. Shubham Pant(@DrShubhamPant) 's Twitter Profile Photo

🤩🤩 To finally see in print The Lancet Oncology .
➡️ True 🌎 Collaborative Effort
Tumor Agnostic Efficacy of 🎯🎯 in Patients with Alt.
➡️One of the Largest Tumor Agnostic basket trials!!!
➡️ Presented at @asco
Link ➡️ urldefense.com/v3/__https://a…

🤩🤩 To finally see in print @TheLancetOncol . 
➡️ True 🌎 Collaborative Effort
Tumor Agnostic Efficacy of #Erdafitinib 🎯🎯 in Patients with #FGFR Alt.
➡️One of the Largest Tumor Agnostic basket trials!!! 
➡️ Presented at @asco #ASCO23
Link ➡️ urldefense.com/v3/__https://a…
account_circle
Ivy Riano, M.D.(@IvyLorena_Md) 's Twitter Profile Photo

Thank you ASCO for featuring my photo in your Instagram feed!

I truly enjoyed connecting with students, residents and fellows at ASCOTECAG lounge

Thank you @ASCO for featuring my photo in your Instagram feed! 

I truly enjoyed connecting with students, residents and fellows at @ASCOTECAG lounge #ASCO23
account_circle
AffyImmune Therapeutics(@affyimmune) 's Twitter Profile Photo

Live from New York, it's... AffyImmune!

Our friends at Ramp gave us a boost in Times Square, featuring a tweet by Center for Technology Licensing at Cornell about our clinical data from

Thanks to Ramp for the surprise and to our partners helping deliver AIC100 to patients in our clinical trial!

Live from New York, it's... AffyImmune! 

Our friends at @tryramp gave us a boost in Times Square, featuring a tweet by @Cornell_CTL about our clinical data from #ASCO23

Thanks to Ramp for the surprise and to our partners helping deliver AIC100 to patients in our clinical trial!
account_circle
Yakup Ergün(@dr_yakupergun) 's Twitter Profile Photo

Topical Diclofenac for Prevention of Capecitabine-Associated Hand-Foot Syndrome: A Double-Blind Randomized Controlled Trial | Journal of Clinical Oncology

Simple solutions to seemingly complex problems👇

Journal of Clinical Oncology ascopubs.org/doi/10.1200/JC…

Topical Diclofenac for Prevention of Capecitabine-Associated Hand-Foot Syndrome: A Double-Blind Randomized Controlled Trial | Journal of Clinical Oncology

Simple solutions to seemingly complex problems👇

@JCO_ASCO #ASCO23  ascopubs.org/doi/10.1200/JC…
account_circle
Hedyeh Ebrahimi(@EbrahimiHedyeh) 's Twitter Profile Photo

1. In my 1st annual ASCO exp, I was privileged to present result of our trial assessing cabo/nivo +/- at
Huge thanks to my mentor Sumanta K. Pal, MD, FASCO & friend Luis A. Meza. Grateful to Kimmie Ng, MD, MPH for selecting our study & Conquer Cancer, the ASCO Foundation for honoring me with merit award.

1. In my 1st annual @ASCO exp, I was privileged to present result of our trial assessing cabo/nivo +/- #CBM588 at #ASCO23 
Huge thanks to my mentor @montypal & friend @LuisMezaco. Grateful to @KimmieNgMD for selecting our study & @ConquerCancerFd for honoring me with merit award.
account_circle
Marlena(@MarlenaDM) 's Twitter Profile Photo

This picture from is very special to me, because the individuals in the picture are very special to me, therefore I had to post it separately. The best from Winship Cancer Institute of Emory University & the founders of GRASP Memories

This picture from #ASCO23 is very special to me, because the individuals in the picture are very special to me, therefore I had to post it separately. The best from @WinshipAtEmory & the founders of @GRASPtweets #ASCO23Memories
account_circle
IMG Oncologists(@IMG_Oncologists) 's Twitter Profile Photo

🚨Excited to announce our FIRST IMG Oncologists Town Hall!!

Our 1st event after IMG CoP session at ✌🏻

We will be talking about future steps and introducing our subcommittees!
Everyone interested in volunteering/learning more are invited to join:
tinyurl.com/5bavjva2

🚨Excited to announce our FIRST IMG Oncologists Town Hall!!

Our 1st event after IMG CoP session at #ASCO23 ✌🏻

We will be talking about future steps and introducing our subcommittees!
Everyone interested in volunteering/learning more are invited to join:
tinyurl.com/5bavjva2
account_circle
LARVOL(@Larvol) 's Twitter Profile Photo

Who said what at the ASCO 2023?

LARVOL CLIN has curated a list of top voices from over 2500+ top oncologists on X and their contributions at the ASCO last year. Click here to know more: bit.ly/4b8kjDo

Who said what at the @ASCO 2023?

@Larvol CLIN has curated a list of top voices from over 2500+ top oncologists on X and their contributions at the ASCO last year. Click here to know more: bit.ly/4b8kjDo

#ASCO23 #ASCO24 #LARVOL #Oncology #CancerResearch
account_circle
LARVOL(@Larvol) 's Twitter Profile Photo

As the ASCO 2024 is around the corner, @LARVOL CLIN has gathered these insights from the top trials as discussed by 2500+ leading oncologists on X.

To explore more insights from last year's conference: bit.ly/4b8kjDo

As the @ASCO 2024 is around the corner, @LARVOL CLIN has gathered these insights from the top trials as discussed by 2500+ leading oncologists on X.

To explore more insights from last year's conference: bit.ly/4b8kjDo

#ASCO23 #ASCO24 #LARVOL #Oncology #CancerResearch
account_circle
LARVOL(@Larvol) 's Twitter Profile Photo

Ready for ASCO 2024?

Have a look at some highlights from ASCO 2023!

@LARVOL CLIN has analysed key discussions from 2500+ leading oncologists on X, focusing on top trials & influencers

Explore more: bit.ly/4b8kjDo

Ready for @ASCO 2024?

Have a look at some highlights from ASCO 2023! 

@LARVOL CLIN has analysed key discussions from 2500+ leading oncologists on X, focusing on top trials & influencers

Explore more: bit.ly/4b8kjDo

#ASCO23 #ASCO24 #LARVOL #Oncology #CancerResearch
account_circle
Ibrahim Halil SAHIN, MD(@IbrahimSahinMD1) 's Twitter Profile Photo

✳️Excited for Pittsburgh Annual Oncology Symposium happening on July 14-15th.

Thrilled to join leading GI faculty Tanios Bekaii-Saab, MD Anwaar Saeed Nilofer Azad❗️

✳️Will be going over updates from ASCO23 to interrogate their impact on our practice❗️Consider registering ‼️
OncoAlert

✳️Excited for Pittsburgh Annual Oncology Symposium happening on July 14-15th.

Thrilled to join leading GI faculty @GIcancerDoc @AnwaarSaeed3 Nilofer Azad❗️

✳️Will be going over updates from ASCO23 to interrogate their impact on our practice❗️Consider registering ‼️
@OncoAlert
account_circle